We are pleased to announce the appointment of Gene Klaft as Territory Manager for the states of Idaho, Washington and Northern Oregon. Gene will be an integral part of US Cattle Sales team. Gene bring...

 Schaumburg, Illinois – Bimeda® US proudly announces the launch of GamrozyneTM, the first and only bioequivalent to Zactran® (Boehringer-Ingelheim®). This milestone expands Bimeda's robust antibi...

We are pleased to announce that Dr. Eric Moore has joined Bimeda as Director of US Technical Services, supporting our Commercial team. Eric brings more than 30 years of leadership and veterinary indus...

Schaumburg, Illinois (May 19, 2025) – Bimeda is pleased to announce the expansion of its anti-parasitic portfolio with the addition of Doracide. Doracide is bioequivalent to Dectomax® Pour-On (Zoetis®...

Schaumburg, Illinois (APRIL 14, 2025) – Bimeda is pleased to announce an expansion to its product portfolio with the addition of SecureCattle, an analog of the naturally secreted bovine appeasing pher...

 AquaTactics, Bimeda's Washington-based aquaculture division, is excited to announce its entry into the autogenous fish vaccine sector, following USDA approval. Autogenous fish vaccine production...

Schaumburg, Illinois – Bimeda is excited to announce the expansion of its anti-parasitic portfolio with the introduction of MoxiSolv Injection (moxidectin). MoxiSolv stands out as the only FDA-approve...

Bimeda is pleased to announce the appointment of Colby Flatt as Senior Territory Manager for the region of Southern Missouri, Eastern Oklahoma and Arkansas. Colby will be an integral part of the US Ca...

Bimeda is pleased to announce the appointment of Casey Story as Senior Territory Manager. Casey will be an integral part of US Cattle Sales team in the states of Kentucky, Tennessee, Mississippi, Alab...

Schaumburg, Illinois – Bimeda, Inc. has recently launched Bimasone, the first generic flumethasone for certain diseases that cause inflammation in horses, dogs and cats including rheumatic, aller...